Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation.

Journal article

Allen JD. et al, (2021), Biochemistry

Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.

Journal article

Redhead MA. et al, (2021), Scientific reports, 11

Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection status.

Journal article

Eyre DW. et al, (2021), Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Antibody evasion by the P.1 strain of SARS-CoV-2

Journal article

Dejnirattisai W. et al, (2021), Cell, 184, 2939 - 2954.e9

Site-specific steric control of SARS-CoV-2 spike glycosylation.

Journal article

Allen JD. et al, (2021), bioRxiv

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.

Journal article

Huo J. et al, (2021), Nature structural & molecular biology

The antigenic anatomy of SARS-CoV-2 receptor binding domain

Journal article

Dejnirattisai W. et al, (2021), Cell

Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey

Journal article

Pouwels KB. et al, (2021), The Lancet Public Health, 6, e30 - e38

Hand-foot-and-mouth disease virus receptor KREMEN1 binds the canyon of Coxsackie Virus A10

Journal article

Zhao Y. et al, (2020), Nature Communications, 11

Low-dose phase retrieval of biological specimens using cryo-electron ptychography

Journal article

Zhou L. et al, (2020), Nature Communications, 11

Diamond Light Source: contributions to SARS-CoV-2 biology and therapeutics.

Journal article

Walsh MA. et al, (2020), Biochemical and biophysical research communications

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.

Journal article

Huo J. et al, (2020), Nature structural & molecular biology, 27

Load More